Developed Markets — Other revenues
Viatris Developed Markets — Other revenues remained flat by 0.0% to $9.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $8.00M to $9.53M. Over 3 years (FY 2022 to FY 2025), Developed Markets — Other revenues shows an upward trend with a 20.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful monetization of intellectual property or secondary business capabilities, diversifying the revenue base.
Detailed definition
Revenue generated within the Developed Markets segment that is not derived from primary product sales, such as royalties...
Peer comparison
Often labeled as 'Other Revenue' or 'Service Revenue' in segment reporting for diversified pharmaceutical firms.
vtrs_segment_developed_markets_other_revenuesHistorical Data
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $21.80M | $26.10M | $32.00M | $38.10M |
| YoY Change | — | +19.7% | +22.6% | +19.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's developed markets — other revenues?
- Viatris (VTRS) reported developed markets — other revenues of $9.53M in Q4 2025.
- How has Viatris's developed markets — other revenues changed year-over-year?
- Viatris's developed markets — other revenues increased by 19.1% year-over-year, from $8.00M to $9.53M.
- What is the long-term trend for Viatris's developed markets — other revenues?
- Over 3 years (2022 to 2025), Viatris's developed markets — other revenues has grown at a 20.5% compound annual growth rate (CAGR), from $21.80M to $38.10M.
- What does developed markets — other revenues mean?
- Non-core revenue streams generated by the Developed Markets segment, such as royalties or service fees.